Monday, January 03, 2022 7:19:49 AM
MOJO Organics Inc Reports 2021 Results
JERSEY CITY, NJ, January 3, 2022// — MOJO Organics Inc. (OTC: MOJO) reports its unaudited results of operations for the Fourth Quarter of 2021 and the year ended December 31, 2021. A Form 8-K was filed with the United States Securities and Exchange Commission.
The SEC Form 10-K is expected to be filed in January with the United States Securities and Exchange Commission.
Highlights include:
? 2021 Net Revenue was $1,923,283 an increase of $181,364 or 10 percent from $1,741,919 for 2020.
? 2021 Net Income was $44,032, an improvement of $127,751 or 153 percent from a Net Loss of $83,719 for 2020.
? 2021 Fourth Quarter Net Revenue was $428,225, an increase of $136,893 or 47 percent from $291,331 for 2020.
? 2021 Fourth Quarter Net Loss was $47,959, an improvement of $28,257 or 38 percent from a Net Loss of $76,816 for 2020.
The Company has 30,661,080 issued and outstanding shares as of January 3, 2022 and 318,108 options with 944 shareholders of record.
Officers and Directors account for 47 percent of the ownership on a fully diluted basis as of January 3, 2022.
The Company has a simple capital structure with one class of stock and no debt, loans or convertible securities.
During 2021, the Company purchased 765,826 shares of its stock.
In January 2022, the Company purchased 750,000 shares of its stock. The Company plans to continue to purchase shares during 2022.
END
--
Glenn Simpson
Chairman and CEO
MOJO Organics In
Recent MOJO News
- Form 8-K - Current report • Edgar (US Regulatory) • 01/10/2024 11:02:02 AM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 12/15/2023 03:35:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/04/2023 02:00:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/01/2023 04:00:25 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 10/18/2023 01:42:31 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/02/2023 05:12:13 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/07/2023 06:00:23 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/03/2023 01:52:40 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/02/2023 05:10:01 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/30/2023 09:00:21 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM